SpaceX vs. Rocket Lab: Which Is the Better Space Stock to Buy Right Now?

The article argues Rocket Lab is the better buy versus SpaceX despite both being volatile. Rocket Lab posted Q1 revenue up 64% to $200M and narrowed its loss to -$0.07/share, while SpaceX reported Q1 sales up only 15% to $4.7B but widened its loss to -$3.29/share as capex surged to $10B in Q1 2026 (vs $27B for all 2025). It also highlights Rocket Lab’s acceleration with 31 new launch contracts plus a planned $8B acquisition of Iridium, while SpaceX faces a much higher valuation (P/S ~94 vs Rocket Lab ~66).

Analysis

The market mechanism here is not "space stocks are good/bad"; it is capacity scarcity versus capital intensity. If one incumbent is forcing a huge capex ramp, that usually tightens near-term launch supply and can support pricing for the smaller public competitor, but it also signals that any future margin pool will be fought over with far deeper pockets. For RKLB, the bullish window is days to a few quarters: backlog conversion, defense awards, and launch cadence can keep the stock bid even if the business is still too early for clean earnings power.

The bigger second-order effect is on the public proxy valuation stack. RKLB can work as a scarcity narrative, but the market is likely to overpay for near-term growth if it assumes a straight line to profitability. The most fragile part of the thesis is integration/execution around any satellite communications expansion: if management has to spend heavily to absorb new assets or to keep launch tempo, the multiple can compress fast on even modest misses. IRDM is the cleaner balance-sheet quality name if a corporate transaction is real and properly documented; otherwise it is the lower-volatility way to express defense/mobility connectivity exposure.

Contrarian view: consensus is treating headline revenue acceleration as durable and capex as merely "investment." The missing piece is that space is still a supply-constrained, failure-prone industry where one launch issue, one delayed contract, or one financing round can reset the story by 20-30% in a single tape. Six to eighteen months out, the key falsifier for RKLB is any evidence that growth decelerates while spending stays elevated; for the broader sector, a successful step-change in reusable launch economics would pressure every incumbent multiple, not just the expensive one.

Key Decisions for Investors

• Tactically long RKLB on weakness only, not strength; use post-rally pullbacks over the next 1-4 weeks as entry, with a 20-25% downside stop if backlog or launch cadence disappoints.
• If any transaction on IRDM is formally filed and the spread is wide enough, evaluate IRDM as a merger-arb / quality-defense vehicle rather than chasing RKLB beta; otherwise keep it on watch, not in portfolio.
• Avoid initiating a fresh short against the sector based solely on SpaceX capex: the near-term supply tightening can keep RKLB elevated for 1-3 months even if the long-run economics are ugly.
• Set a watchpoint on the next RKLB quarter: if revenue growth falls below ~40% year over year or operating losses stop improving, the stock is vulnerable to a sharp multiple reset.
• No trade on GOOGL/MS/NVDA from this note alone; treat any AI/compute adjacency as optionality until there is independently verifiable revenue impact.